AGENTIX

Agentix is a biopharmaceutical company that focuses on the development of a suite of health solutions for patients and consumers. The company also focused on the development of synthetic agonists, inverse agonists, and antagonists that modulate the endocannabinoid system (ECS). The ECS is a network of G-protein coupled receptors (GPCRs) that help regulate a variety of metabolic and neurotransmission functions. GPCRs are considered the largest family of proven therapeutic targets. Agentix was founded in 2013 and is headquartered in Dana Point, California.